Sports medicine revenue from the acquisition of Parcus Medical and Arthrosurface helped Anika navigate the low point of the COVID orthopedic market in 2Q20.
Amplitude's sales fell nearly -14% for their fiscal year 2020 due to COVID-19, but the company's foot and ankle products still managed double-digit growth.
Medicrea announced that it entered into an agreement to be acquired by Medtronic at a price of €7 (USD $8.01) per share with a 2020 estimated close date.
We expect 2Q20 orthopedic performance above consensus projections, but the U.S.’s inability to check the spread of COVID-19 will slow market recovery.